Aimei Health Technology (AFJK) Competitors $11.17 0.00 (0.00%) As of 08/14/2025 11:07 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AFJK vs. CEPO, SBXD, INV, PLMK, NREF, OACC, FVR, SVCC, WTF, and SAMGShould you be buying Aimei Health Technology stock or one of its competitors? The main competitors of Aimei Health Technology include Cantor Equity Partners (CEPO), SilverBox Corp IV (SBXD), Innventure (INV), Plum Acquisition Corp. IV (PLMK), NexPoint Real Estate Finance (NREF), Oaktree Acquisition Corp. III Life Sciences (OACC), FrontView REIT (FVR), Stellar V Capital (SVCC), Waton Financial (WTF), and Silvercrest Asset Management Group (SAMG). These companies are all part of the "trading" industry. Aimei Health Technology vs. Its Competitors Cantor Equity Partners SilverBox Corp IV Innventure Plum Acquisition Corp. IV NexPoint Real Estate Finance Oaktree Acquisition Corp. III Life Sciences FrontView REIT Stellar V Capital Waton Financial Silvercrest Asset Management Group Aimei Health Technology (NASDAQ:AFJK) and Cantor Equity Partners (NASDAQ:CEPO) are both small-cap financial services companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, media sentiment, valuation, earnings, institutional ownership and dividends. Does the media favor AFJK or CEPO? In the previous week, Aimei Health Technology and Aimei Health Technology both had 5 articles in the media. Cantor Equity Partners' average media sentiment score of 1.83 beat Aimei Health Technology's score of 1.38 indicating that Cantor Equity Partners is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aimei Health Technology 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cantor Equity Partners 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Is AFJK or CEPO more profitable? Cantor Equity Partners' return on equity of 0.00% beat Aimei Health Technology's return on equity.Company Net Margins Return on Equity Return on Assets Aimei Health TechnologyN/A -95.88% 3.06% Cantor Equity Partners N/A N/A N/A Do institutionals & insiders have more ownership in AFJK or CEPO? 45.6% of Aimei Health Technology shares are held by institutional investors. 1.7% of Aimei Health Technology shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has higher valuation and earnings, AFJK or CEPO? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAimei Health TechnologyN/AN/A$2.55MN/AN/ACantor Equity PartnersN/AN/A-$80KN/AN/A SummaryAimei Health Technology beats Cantor Equity Partners on 4 of the 6 factors compared between the two stocks. Get Aimei Health Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for AFJK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AFJK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AFJK vs. The Competition Export to ExcelMetricAimei Health TechnologyUNCLASSIFIED IndustryFinancial SectorNASDAQ ExchangeMarket Cap$68.62M$181.85M$6.45B$9.82BDividend YieldN/AN/A4.17%4.07%P/E Ratio48.571.9014.2325.12Price / SalesN/A46.711,860.08115.60Price / Cash39.6576.47127.1259.05Price / Book-23.77190.335.216.18Net Income$2.55M-$1.39M$1.23B$264.89M7 Day Performance-0.26%-0.61%0.74%4.18%1 Month Performance0.19%-3.13%2.32%1.99%1 Year Performance7.40%97.04%27.89%24.22% Aimei Health Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AFJKAimei Health TechnologyN/A$11.17flatN/A+7.4%$68.62MN/A48.57N/ANews CoveragePositive NewsEarnings ReportCEPOCantor Equity PartnersN/A$10.63-1.4%N/AN/A$271.07MN/A0.002Positive NewsSBXDSilverBox Corp IVN/A$10.60-0.4%N/AN/A$269.77MN/A0.00N/ANews CoverageEarnings ReportINVInnventure2.8449 of 5 stars$4.84-6.6%$14.00+189.3%N/A$258.89M$1.22M0.00N/ANews CoverageEarnings ReportGap DownPLMKPlum Acquisition Corp. IVN/A$10.29+0.1%N/AN/A$249.43MN/A0.002News CoveragePositive NewsHigh Trading VolumeNREFNexPoint Real Estate Finance2.5281 of 5 stars$13.83+0.1%$14.75+6.7%-5.0%$244.84M$72.51M5.741OACCOaktree Acquisition Corp. III Life SciencesN/A$10.47flatN/AN/A$234.74MN/A0.00N/ANews CoveragePositive NewsFVRFrontView REIT1.7512 of 5 stars$12.10+1.5%$15.10+24.8%N/A$230.99M$66.68M0.00N/ANews CoverageDividend AnnouncementSVCCStellar V CapitalN/A$10.27flatN/AN/A$221.94MN/A0.003News CoveragePositive NewsWTFWaton FinancialN/A$4.65-0.2%N/AN/A$221.25MN/A0.0031Positive NewsGap UpSAMGSilvercrest Asset Management Group3.3825 of 5 stars$16.37+1.4%N/A+5.1%$219.52M$123.65M18.60150Positive NewsDividend Increase Related Companies and Tools Related Companies CEPO Competitors SBXD Competitors INV Competitors PLMK Competitors NREF Competitors OACC Competitors FVR Competitors SVCC Competitors WTF Competitors SAMG Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AFJK) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump's New Plan to “Make China Pay”Trump's AI Masterplan Could Crush China The White House just unleashed would could be the most aggressive e...Stansberry Research | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aimei Health Technology Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aimei Health Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access